| RS121908199 |
TPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS121908200 |
TPP1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 2, Inborn genetic diseases |
| RS121908201 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS121908202 |
TPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis |
| RS121908203 |
TPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Autosomal recessive spinocerebellar ataxia 7 |
| RS121908204 |
TPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis |
| RS121908205 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS121908207 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 2 |
| RS121908208 |
TPP1
|
Health Risk |
Likely pathogenic |
— |
| RS121908209 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis |
| RS121908211 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Migraine, familial hemiplegic |
| RS121908212 |
CACNA1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121908213 |
CACNA1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121908214 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS121908215 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia type 6, Episodic ataxia type 2 |
| RS121908216 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS121908217 |
CACNA1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121908218 |
CACNA1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121908219 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Migraine, familial hemiplegic |
| RS121908220 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Migraine, familial hemiplegic |
| RS121908222 |
CACNA1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121908224 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS121908225 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS121908226 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS121908227 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS121908228 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS121908230 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS121908233 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS121908235 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS121908236 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS121908237 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS121908240 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS121908242 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS121908243 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS121908247 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia type 6, Chronic and progressive ataxia |
| RS121908248 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS121908249 |
ENPP1
|
Health Risk |
Pathogenic |
Hypophosphatemic rickets, autosomal recessive |
| RS121908250 |
CCBE1
|
Health Risk |
Pathogenic |
Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 1 |
| RS121908251 |
CCBE1
|
Health Risk |
Pathogenic |
Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 1 |
| RS121908252 |
CCBE1
|
Health Risk |
Pathogenic |
Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 1 |
| RS121908253 |
CCBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hennekam lymphangiectasia-lymphedema syndrome 1, CCBE1-related disorder |
| RS121908254 |
CCBE1
|
Health Risk |
Pathogenic |
Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 1 |
| RS121908255 |
CBX2
|
Health Risk |
Pathogenic |
46, XY sex reversal 5 |
| RS121908256 |
CBX2
|
Health Risk |
Pathogenic |
46, XY sex reversal 5 |
| RS121908257 |
CHST14
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, musculocontractural type |
| RS121908258 |
CHST14
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, musculocontractural type |
| RS121908259 |
INS
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 10, INS-related disorder |
| RS121908260 |
INS
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 10, Diabetes mellitus |
| RS121908261 |
INS
|
Health Risk |
Pathogenic/Likely pathogenic/Likely risk allele |
Type 1 diabetes mellitus 2, Diabetes mellitus type 1 |
| RS121908273 |
INS
|
Health Risk |
Likely risk allele |
Diabetes mellitus, permanent neonatal 4 |
| RS121908276 |
INS
|
Health Risk |
Likely risk allele |
Permanent neonatal diabetes mellitus, Diabetes mellitus |
| RS121908277 |
INS
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Diabetes mellitus |
| RS121908278 |
INS
|
Health Risk |
Likely risk allele |
Maturity-onset diabetes of the young type 10, Maturity-onset diabetes of the young type 10 |
| RS121908281 |
RAX2
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 11, Cone-rod dystrophy 11 |
| RS121908282 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS121908283 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS121908284 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-C |
| RS121908285 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-C |
| RS121908286 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS121908287 |
FIG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4J, Amyotrophic lateral sclerosis type 11 |
| RS121908288 |
FIG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 11, Charcot-Marie-Tooth disease type 4J |
| RS121908290 |
FIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 11, Amyotrophic lateral sclerosis |
| RS121908291 |
PALLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pancreatic cancer, susceptibility to |
| RS121908292 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS121908293 |
ALG8
|
Health Risk |
Pathogenic |
ALG8 congenital disorder of glycosylation, Polycystic liver disease 3 with or without kidney cysts |
| RS121908294 |
ALG8
|
Health Risk |
Likely pathogenic |
ALG8 congenital disorder of glycosylation, Polycystic liver disease 3 with or without kidney cysts |
| RS121908295 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type II, Lewy body dementia |
| RS121908297 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gaucher disease type I, Gaucher disease type I |
| RS121908298 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS121908299 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS121908301 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gaucher disease type I, Gaucher disease type I |
| RS121908302 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS121908303 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS121908304 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS121908305 |
GBA1
|
Health Risk |
Likely pathogenic |
Gaucher disease type II, Gaucher disease |
| RS121908306 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type II, Gaucher disease type II |
| RS121908307 |
GBA1
|
Health Risk |
Likely pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS121908308 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease type III, Gaucher disease type I |
| RS121908309 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease perinatal lethal, Gaucher disease |
| RS121908310 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease perinatal lethal, Gaucher disease perinatal lethal |
| RS121908311 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease type III, Gaucher disease type I |
| RS121908312 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease type I, Gaucher disease type III |
| RS121908313 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease perinatal lethal, Gaucher disease perinatal lethal |
| RS121908314 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS121908315 |
PIP5K1C
|
Health Risk |
Pathogenic |
Lethal congenital contracture syndrome 3, Lethal congenital contracture syndrome 3 |
| RS121908316 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome |
| RS121908317 |
SLURP1
|
Health Risk |
Pathogenic |
Acroerythrokeratoderma, Acroerythrokeratoderma |
| RS121908318 |
SLURP1
|
Health Risk |
Pathogenic |
Acroerythrokeratoderma, Acroerythrokeratoderma |
| RS121908319 |
SLURP1
|
Health Risk |
Pathogenic |
Acroerythrokeratoderma, Acroerythrokeratoderma |
| RS121908320 |
SLURP1
|
Health Risk |
Pathogenic |
Acroerythrokeratoderma, Acroerythrokeratoderma |
| RS121908321 |
SLC2A9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypouricemia, renal |
| RS121908322 |
SLC2A9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypouricemia, renal |
| RS121908323 |
SLC2A9
|
Health Risk |
Pathogenic |
Hypouricemia, renal |
| RS121908324 |
LDLRAP1
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS121908325 |
LDLRAP1
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS121908326 |
LDLRAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS121908327 |
TMC6
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, susceptibility to |
| RS121908328 |
TMC6
|
Health Risk |
risk factor |
Epidermodysplasia verruciformis, susceptibility to |
| RS121908329 |
TMC6
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, susceptibility to |
| RS121908330 |
TMC8
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, susceptibility to |